Opko Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Opko Health
OPK Stock  USD 1.72  0.06  3.37%   
Opko Health financial statements provide useful quarterly and yearly information to potential Opko Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Opko Health financial statements helps investors assess Opko Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Opko Health's valuation are summarized below:
Gross Profit
113.3 M
Profit Margin
(0.07)
Market Capitalization
1.2 B
Enterprise Value Revenue
1.7779
Revenue
713.1 M
There are currently one hundred twenty trending fundamental ratios for Opko Health that can be evaluated and compared over time across competitors. We recommend to check out Opko Health's recent fundamental drivers against the all of the trends between 2010 and 2025. Market Cap is expected to rise to about 1.4 B this year. Enterprise Value is expected to rise to about 1.4 B this year

Opko Health Total Revenue

435.22 Million

Check Opko Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Opko Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 103.1 M, Interest Expense of 49.8 M or Total Revenue of 435.2 M, as well as many indicators such as Price To Sales Ratio of 1.36, Dividend Yield of 0.0011 or PTB Ratio of 0.71. Opko financial statements analysis is a perfect complement when working with Opko Health Valuation or Volatility modules.
  
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Opko Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.3 B2.2 B1.9 B
Slightly volatile
Other Current Liabilities66.2 M96.1 M97 M
Slightly volatile
Total Current Liabilities107.5 M193.1 M185.8 M
Slightly volatile
Total Stockholder Equity707.7 M1.4 B1.2 B
Slightly volatile
Property Plant And Equipment Net130.3 M124.1 M99.3 M
Slightly volatile
Accounts Payable26.9 M47.1 M46 M
Slightly volatile
Cash453.5 M431.9 M147.8 M
Slightly volatile
Non Current Assets Total872.7 M1.5 B1.4 B
Slightly volatile
Non Currrent Assets Other279.5 M213.5 M366.7 M
Slightly volatile
Cash And Short Term Investments453.5 M431.9 M147.8 M
Slightly volatile
Common Stock Shares Outstanding728.7 M694 M516.3 M
Slightly volatile
Liabilities And Stockholders Equity2.3 B2.2 B1.9 B
Slightly volatile
Total Liabilities876.5 M834.8 M572.4 M
Slightly volatile
Property Plant And Equipment Gross276 M262.8 M144.1 M
Slightly volatile
Total Current Assets695.2 M662.1 M369.1 M
Slightly volatile
Intangible Assets576.9 M616.6 M885.9 M
Slightly volatile
Non Current Liabilities Total673.8 M641.7 M380.7 M
Slightly volatile
Short and Long Term Debt Total555 M528.5 M206.2 M
Slightly volatile
Other Current Assets61.6 M55.3 M100.6 M
Pretty Stable
Short Term Debt17.9 M27.7 M23.1 M
Slightly volatile
Common Stock Total Equity8.3 M7.9 M5.5 M
Slightly volatile
Common Stock3.8 M7 M5.2 M
Slightly volatile
Other Liabilities142 M145.4 M154.5 M
Slightly volatile
Other Assets1.2 B1.1 B341.3 M
Slightly volatile
Property Plant Equipment149.7 M142.5 M100.7 M
Slightly volatile
Current Deferred Revenue28.2 M43.4 M29 M
Slightly volatile
Inventory43.5 M56.8 M47.6 M
Slightly volatile
Good Will430.6 M529.3 M466.6 M
Slightly volatile
Capital Surpluse2.5 B3.7 B2.4 B
Slightly volatile
Long Term Investments29 M54.6 M25.3 M
Slightly volatile
Non Current Liabilities Other10.9 M11.5 M238.2 M
Slightly volatile
Warrants19.5 M21.9 M23.9 M
Slightly volatile
Short and Long Term Debt21.1 M15 M17.1 M
Slightly volatile
Long Term Debt Total167.7 M303.5 M177.2 M
Slightly volatile
Capital Lease Obligations44.6 M67.2 M29.4 M
Slightly volatile
Net Invested Capital1.3 B1.8 B1.8 B
Slightly volatile
Net Working Capital492.4 M469 M147.6 M
Slightly volatile
Capital Stock7.7 M7 M6.5 M
Slightly volatile

Opko Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization103.1 M98.2 M41.7 M
Slightly volatile
Total Revenue435.2 M713.1 M691.3 M
Slightly volatile
Other Operating Expenses455.6 M865.2 M792.2 M
Slightly volatile
Cost Of Revenue290.6 M402.1 M460.8 M
Slightly volatile
Total Operating Expenses486.3 M463.1 M382.9 M
Slightly volatile
Selling General Administrative319.4 M304.2 M262.1 M
Slightly volatile
Research Development110.5 M105.2 M80.1 M
Slightly volatile
Selling And Marketing Expenses522.4 K587.7 K640.8 K
Slightly volatile
Discontinued Operations93.2 K98.1 K741.3 K
Slightly volatile
Preferred Stock And Other Adjustments359.1 K378 K772.2 K
Slightly volatile
Interest Income5.3 M8.4 M19.2 M
Slightly volatile
Reconciled Depreciation102 M98.2 M97.4 M
Pretty Stable

Opko Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow61.2 M95.9 M97.1 M
Slightly volatile
Depreciation103.1 M98.2 M66 M
Slightly volatile
End Period Cash Flow467.9 M445.6 M149.5 M
Slightly volatile
Stock Based Compensation15 M11 M15.5 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.361.430625.043
Slightly volatile
Dividend Yield0.00110.00120.0013
Slightly volatile
PTB Ratio0.710.74722.6357
Slightly volatile
Days Sales Outstanding57.3860.4034133
Slightly volatile
Book Value Per Share1.191.96742.2825
Pretty Stable
Average Payables75.6 M75.5 M71.9 M
Pretty Stable
Stock Based Compensation To Revenue0.01470.01550.598
Slightly volatile
Capex To Depreciation0.240.25470.3536
Slightly volatile
PB Ratio0.710.74722.6357
Slightly volatile
EV To Sales1.491.56621.6021
Slightly volatile
Inventory Turnover5.987.07988.5538
Slightly volatile
Days Of Inventory On Hand48.9851.5554134
Slightly volatile
Payables Turnover4.98.54269.1026
Pretty Stable
Sales General And Administrative To Revenue3.24.414.586
Very volatile
Research And Ddevelopement To Revenue0.140.14750.3097
Slightly volatile
Capex To Revenue0.03330.03510.0358
Slightly volatile
Cash Per Share0.50.62240.3224
Pretty Stable
Intangibles To Total Assets0.310.52080.5435
Very volatile
Current Ratio3.263.42882.2666
Pretty Stable
Receivables Turnover3.626.04274.5062
Slightly volatile
Shareholders Equity Per Share1.191.96742.2832
Pretty Stable
Debt To Equity0.370.38710.1454
Slightly volatile
Capex Per Share0.02020.0360.0311
Slightly volatile
Average Receivables144.9 M124.1 M138.8 M
Pretty Stable
Revenue Per Share0.541.02761.1446
Slightly volatile
Interest Debt Per Share0.870.830.3314
Slightly volatile
Debt To Assets0.250.24020.0961
Slightly volatile
Graham Number1.341.511.643
Slightly volatile
Operating Cycle106112267
Slightly volatile
Price Book Value Ratio0.710.74722.6357
Slightly volatile
Ebt Per Ebit0.06470.06810.9666
Slightly volatile
Company Equity Multiplier1.531.61131.4421
Slightly volatile
Long Term Debt To Capitalization0.210.26840.134
Very volatile
Total Debt To Capitalization0.180.27910.1138
Slightly volatile
Debt Equity Ratio0.370.38710.1454
Slightly volatile
Quick Ratio2.983.13471.9982
Pretty Stable
Net Income Per E B T5.395.13651.4165
Slightly volatile
Cash Ratio2.132.23691.234
Slightly volatile
Cash Conversion Cycle65.7769.2318183
Slightly volatile
Days Of Inventory Outstanding48.9851.5554134
Slightly volatile
Days Of Sales Outstanding57.3860.4034133
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.13630.9817
Very volatile
Price To Book Ratio0.710.74722.6357
Slightly volatile
Fixed Asset Turnover5.425.74486.5375
Slightly volatile
Debt Ratio0.250.24020.0961
Slightly volatile
Price Sales Ratio1.361.430625.043
Slightly volatile
Asset Turnover0.190.32410.3095
Slightly volatile
Price Fair Value0.710.74722.6357
Slightly volatile

Opko Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.4 B1 B1.9 B
Pretty Stable
Enterprise Value1.4 B1.1 B2 B
Pretty Stable

Opko Fundamental Market Drivers

Forward Price Earnings64.5161
Cash And Short Term Investments431.9 M

Opko Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Opko Health Financial Statements

Opko Health investors utilize fundamental indicators, such as revenue or net income, to predict how Opko Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue43.4 M28.2 M
Total Revenue713.1 M435.2 M
Cost Of Revenue402.1 M290.6 M
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 4.41  3.20 
Research And Ddevelopement To Revenue 0.15  0.14 
Capex To Revenue 0.04  0.03 
Revenue Per Share 1.03  0.54 
Ebit Per Revenue(0.21)(0.22)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
How To Invest In Opko
Details
Is Opko Stock a good investment?
Details
What is Opko Health's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.191
Earnings Share
(0.08)
Revenue Per Share
1.028
Quarterly Revenue Growth
0.01
Return On Assets
(0.08)
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY